Wang Y, Wang J. Modelling and prediction of global non-communicable diseases. BMC Public Health. 2020;20:1–13.

Article  Google Scholar 

Xu W, Yang T, Zhang J, Li H, Guo M. Rhodiola rosea: a review in the context of PPPM approach. EPMA Journal. 2024;15(2):233–59.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Invisible numbers: the true extent of noncommunicable diseases and what to do about them. World Health Organization. 2022.

Regional Committee For The Western Pacific. Noncommunicable disease prevention and control. 2022; WHO Regional Office for the Western Pacific: Manila.

Malta DC, Gomes CS, Veloso GA, Dias de Andrade FM, Souza JB, Freitas PC, et al. Burden of non-communicable diseases and the achievement of the sustainable development goals in 2030 in Mercosur countries. Public Health. 2023; 223: 162–170.

Zmaili M, Alzubi J, Alkhayyat M, Albakri A, Alkhalaileh F, Longinow J, et al. Cancer and cardiovascular disease: the conjoined twins. Cancers. 2024;16(8):1450.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Langenberg C, Hingorani AD, Whitty CJM. Biological and functional multimorbidity—from mechanisms to management. Nat Med. 2023;29(7):1649–57.

Article  PubMed  CAS  Google Scholar 

Kopp W. Pathogenesis of (smoking-related) non-communicable diseases—evidence for a common underlying pathophysiological pattern. Front Physiol. 2022;13:1037750.

Article  PubMed  PubMed Central  Google Scholar 

Crisóstomo L, Oliveira PF, Alves MG. Antioxidants, oxidative stress, and non-communicable diseases. Antioxidants. 2022;11(6):1080.

Article  PubMed  PubMed Central  Google Scholar 

Hosseinkhani F, Heinken A, Thiele I, Lindenburg PW, Harms AC, Hankemeier T. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes. 2021;13(1):1882927.

Article  PubMed  PubMed Central  Google Scholar 

Bangar NS, Gvalani A, Ahmad S, Khan MS, Tupe RS. Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies. Glycobiology. 2022;32(12):1068–88.

Article  PubMed  CAS  Google Scholar 

Wu H, Wang Y, Zhang Y, Xu F, Chen J, Duan L, et al. Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress. Redox Biol. 2020;32:101500.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Campbell C, Kandalgaonkar MR, Golonka RM, Yeoh BS, Vijay-Kumar M, Saha P. Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy. Biomedicines. 2023;11(2):294.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baptista BG, Lima LS, Ribeiro M, Britto IK, Alvarenga L, Kemp JA. Royal jelly: a predictive, preventive and personalised strategy for novel treatment options in non-communicable diseases. EPMA Journal. 2023;14(3):381–404.

Article  PubMed  PubMed Central  Google Scholar 

Phillips EM, Frates EP, Park DJ. Lifestyle medicine. Phys Med Rehabil Clin N Am. 2020;31(4):515–26.

Article  PubMed  Google Scholar 

Cena H, Calder PC. Defining a healthy diet: evidence for the role of contemporary dietary patterns in health and disease. Nutrients. 2020;12(2):334.

Article  PubMed  PubMed Central  Google Scholar 

Garza-Juárez A, Pérez-Carrillo E, Arredondo-Espinoza EU, Islas JF, Benítez-Chao DF, Escamilla-García E. Nutraceuticals and their contribution to preventing noncommunicable diseases. Foods. 2023;12(17):3262.

Article  PubMed  PubMed Central  Google Scholar 

Greenway FL. Food as medicine for chronic disease: a strategy to address non-compliance. J Med Food. 2020;23(9):903–4.

Article  PubMed  PubMed Central  Google Scholar 

Kalra EK. Nutraceutical-definition and introduction Aaps Pharmsci. 2003;5(3):25.

Google Scholar 

Chen J. Essential role of medicine and food homology in health and wellness. Chinese herbal medicines. 2023;15(3):347.

Article  PubMed  PubMed Central  Google Scholar 

Xing NN, Qu HD, Ren WC, MA W. Research progress on main chemical constituents and modern pharmacological effects of Schisandra chinensis. Chinese Journal of Experimental Traditional Medical Formulae. 2021; 27(15): 210–218.

Yang K, Qiu J, Huang Z, Yu Z, Wang W, Hu H, et al. A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils. J Ethnopharmacol. 2022;284:114759.

Article  PubMed  CAS  Google Scholar 

Kopustinskiene DM, Bernatoniene J. Antioxidant effects of Schisandra chinensis fruits and their active constituents. Antioxidants. 2021;10(4):620.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rybnikář M, Malaník M, Šmejkal K, Švajdlenka E, Shpet P, Babica P, et al. Dibenzocyclooctadiene lignans from Schisandra chinensis with anti-inflammatory effects. Int J Mol Sci. 2024;25(6):3465.

Article  PubMed  PubMed Central  Google Scholar 

Luo W, Lin K, Hua J, Han J, Zhang Q, Chen L, et al. Schisandrin B attenuates diabetic cardiomyopathy by targeting MyD88 and inhibiting MyD88-dependent inflammation. Adv Sci. 2022;9(31):2202590.

Article  CAS  Google Scholar 

Yan LS, Zhang SF, Luo G, Cheng BC, Zhang C, Wang YW, et al. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Metabolism. 2022;131:155200.

Article  PubMed  CAS  Google Scholar 

Jiang J, Cheng R, Song A, Lou Y, Fan G. Multi-omics analysis reveals mechanism of Schisandra chinensis lignans and acteoside on EMT in hepatoma cells via ERK1/2 pathway. Funct Integr Genomics. 2024;24(3):112.

Article  PubMed  CAS  Google Scholar 

Ko YH, Jeong M, Jang DS, Choi JH. Gomisin L1, a lignan isolated from Schisandra berries, induces apoptosis by regulating NADPH oxidase in human ovarian cancer cells. Life. 2021;11(8):858.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pu H, Qian Q, Wang F, Gong M, Ge X. Schizandrin A induces the apoptosis and suppresses the proliferation, invasion and migration of gastric cancer cells by activating endoplasmic reticulum stress. Mol Med Rep. 2021;24(5):787.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu L, Wang Y, Lv W, Wu X, Sheng H, He C. Schizandrin A can inhibit non-small cell lung cancer cell proliferation by inducing cell cycle arrest, apoptosis and autophagy. Int J Mol Med. 2021;48(6):1–13.

Article  Google Scholar 

Co VA, El-Nezami H, Liu Y, Twum B, Dey P, Cox PA. Schisandrin B suppresses colon cancer growth by inducing cell cycle arrest and apoptosis: molecular mechanism and therapeutic potential. ACS Pharmacol Transl Sci. 2024;7(3):863–77.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gao J, Yu Z, Jing S, Jiang W, Liu C, Yu C. Protective effect of Anwulignan against D-galactose-induced hepatic injury through activating p38 MAPK–Nrf2–HO-1 pathway in mice. Clinical interventions in aging. 2018; 1859–1869.

Li X, Gao J, Yu Z, Jiang W, Sun W, Yu C. Regulatory effect of anwulignan on the immune function through its antioxidation and anti-apoptosis in D-galactose-induced aging mice. Clin Interv Aging. 2020. https://doi.org/10.2147/CIA.S237601.

Article  PubMed  PubMed Central  Google Scholar 

Sun Y, Yan T, Gong G, Li Y, Zhang J, Wu B. Antidepressant-like effects of Schisandrin on lipopolysaccharide-induced mice: Gut microbiota, short chain fatty acid and TLR4/NF-κB signaling pathway. Int Immunopharmacol. 2020;89:107029.

Article  PubMed  CAS  Google Scholar 

Fu J, Li J, Sun Y, Liu S, Song F, Liu Z. In-depth investigation of the mechanisms of Schisandra chinensis polysaccharide mitigating Alzheimer’s disease rat via gut microbiota and feces metabolomics. Int J Biol Macromol. 2023;232:123488.

Article  PubMed  CAS